You are here
PROVID PHARMACEUTICALS INC.
UEI: TNNMX4JCPCE8
# of Employees: 8
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
TRAIL Upregulation by TIC10 Analogs
Amount: $224,960.00Project Summary/Abstract TIC10 (ONC201) is a first-in-class antitumor agent and small molecule inducer of the TRAIL gene which was identified in a high-throughput small molecule library screen in the ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
F11R antagonists for atherosclerosis
Amount: $175,200.00DESCRIPTION (provided by applicant): The proposed research is directed toward the discovery of novel peptide inhibitors of platelet adhesion to the inflamed endothelium that would have value in the pr ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
402- RFP: N43-CM-87007-68 TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUEST
Amount: $149,558.00This project aims to further develop 10-aryl deazaflavin compounds that have been shown to be inhibitors of HDM2's ubiquitin ligase.
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
MEDICINAL CHEMISTRY LEAD OPTIMIZATION, (PHASE II) SBIR TOPIC 198
Amount: $150,000.00N/A
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Design and Assay of DQ2 Inhibitors for Celiac Disease
Amount: $106,881.00DESCRIPTION (provided by applicant): Celiac disease, also known as celiac sprue, is a inflammatory disease affecting the small intestine that results from an immunological reaction to dietary glutens ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Inhibitors of Protein Kinase A Localization in the Heart
Amount: $132,414.00DESCRIPTION (provided by applicant): Cell permeable peptide inhibitors of protein kinase (PKA) sub-cellular localization will be designed to identify signal transduction pathways in cardiac myocytes t ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
MEDICINAL CHEMISTRY LEAD OPTIMIZATION, (PHASE II) SBIR TOPIC 198
Amount: $375,000.00N/A
SBIRPhase II2005Department of Health and Human Services National Institutes of Health -
MEDICINAL CHEM LEAD OPTIMIZATION, SBIR TOPIC 198
Amount: $109,991.00N/A
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
QBP1 Mimetics as Therapeutics for Huntington's Disease
Amount: $187,995.00DESCRIPTION (provided by applicant): Polyglutamine diseases are a group of inherited neurodegenerative diseases, including Huntington's disease, caused by abnormal expansions of the polyglutamine stre ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
MHC Class II inhibitors for Multiple Sclerosis
Amount: $109,997.00DESCRIPTION (provided by applicant): MS is an autoimmune disease affecting over 350,000 patients in the US in which the immune system attacks the myelin sheaths that insulate CNS axons, with secondary ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health